Naringenin Eye Drops Inhibit Corneal Neovascularization by Anti-Inflammatory and Antioxidant Mechanisms
Open Access
- 1 November 2017
- journal article
- research article
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 58 (13) , 5764-5776
Abstract
Purpose: To investigate the effect of naringenin eye drops in corneal neovascularization induced by alkali (1 N NaOH) burn in mice. Methods: Corneal neovascularization in the right eye of male Swiss mice was induced by alkali. Treatment with naringenin eye drops (0.08–80 μg; 8 μL of 0.01–10 g/L solution) or vehicle (saline) started 2 days before corneal neovascularization was induced and was performed twice a day. Mice were treated up until the time animals were euthanized and cornea tissue was collected for testing, which was 2, 4, and 6 hours after alkali stimulus for cytokine and antioxidant capacity measurements, and 3 and/or 7 days after alkali stimulus for the assessment of corneal epithelial thickness and neovascularization, neutrophil, and macrophage recruitment, and vascular endothelial growth factor (Vegf), platelet-derived growth factor (Pdgf), matrix metalloproteinase-14 (Mmp14), and pigment epithelium-derived factor (Pedf) mRNA expression. Results: Naringenin eye drops inhibited alkali burn–induced neutrophil (myeloperoxidase activity and recruitment of Lysm-GFP+ cells) and macrophage (N-acetyl-β-D glucosaminidase activity) recruitment into the eye, decrease in epithelial thickness, and neovascularization in the cornea. Further, naringenin inhibited alkali-induced cytokine (IL-1β and IL-6) production, Vegf, Pdgf, and Mmp14 mRNA expression, and the reduction of ferric reducing antioxidant power and Azinobis-(3-Ethylbenzothiazoline 6-Sulfonic acid) radical scavenging capacity as well as increased the reduced glutathione and protein-bound sulfhydryl groups levels. Conclusions: Collectively, these results indicate that naringenin eye drops are protective in alkali-induced corneal burn by inhibiting leukocyte recruitment, the proangiogenic factor expression, inflammatory cytokine production, and loss of antioxidant defenses.Keywords
This publication has 61 references indexed in Scilit:
- Achieving the Balance between ROS and Antioxidants: When to Use the Synthetic AntioxidantsOxidative Medicine and Cellular Longevity, 2013
- Flavonoid Naringenin: A Potential Immunomodulator forChlamydia trachomatisInflammationMediators of Inflammation, 2013
- Novel role of p66Shc in ROS-dependent VEGF signaling and angiogenesis in endothelial cellsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2012
- Immunity, Inflammation, and CancerCell, 2010
- Vascular endothelial growth factor in eye diseaseProgress in Retinal and Eye Research, 2008
- Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapyCancer Letters, 2008
- Matrix metalloproteinases and the regulation of tissue remodellingNature Reviews Molecular Cell Biology, 2007
- Corneal avascularity is due to soluble VEGF receptor-1Nature, 2006
- Inflammation and cancerNature, 2002
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971